Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study

Jonas Bjerring Olesen; Gunnar H Gislason; Mette G Charlot; Emil Loldrup Fosbøl; Charlotte Andersson; Peter Weeke; Ole Ahlehoff; Christian Laust Weise Selmer; Christian Torp-Pedersen; Peter R Hansen

doi:10.1016/j.jacc.2010.08.640

Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study

Jonas Bjerring Olesen, Gunnar H Gislason, Mette G Charlot, Emil Loldrup Fosbøl, Charlotte Andersson, Peter Weeke, Ole Ahlehoff, Christian Laust Weise Selmer, Christian Torp-Pedersen, Peter R Hansen

40 Citations (Scopus)

Abstract

The purpose of this study was to determine the risk of adverse cardiovascular events associated with concomitant use of clopidogrel and calcium-channel blockers (CCBs) in patients with myocardial infarction (MI).

Original language	English
Journal	Journal of the American College of Cardiology
Volume	57
Issue number	4
Pages (from-to)	409-17
Number of pages	9
DOIs	https://doi.org/10.1016/j.jacc.2010.08.640
Publication status	Published - 25 Jan 2011

Access to Document

10.1016/j.jacc.2010.08.640

Cite this

Olesen, J. B., Gislason, G. H., Charlot, M. G., Fosbøl, E. L., Andersson, C., Weeke, P., Ahlehoff, O., Selmer, C. L. W., Torp-Pedersen, C., & Hansen, P. R. (2011). Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study. Journal of the American College of Cardiology, 57(4), 409-17. https://doi.org/10.1016/j.jacc.2010.08.640

Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study. / Olesen, Jonas Bjerring ; Gislason, Gunnar H ; Charlot, Mette G et al.
In: Journal of the American College of Cardiology, Vol. 57, No. 4, 25.01.2011, p. 409-17.

Research output: Contribution to journal › Journal article › Research › peer-review

Olesen, JB , Gislason, GH , Charlot, MG , Fosbøl, EL , Andersson, C , Weeke, P , Ahlehoff, O , Selmer, CLW , Torp-Pedersen, C & Hansen, PR 2011, 'Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study', Journal of the American College of Cardiology, vol. 57, no. 4, pp. 409-17. https://doi.org/10.1016/j.jacc.2010.08.640

@article{e882c754320a46b8b154b6195a3fdbed,

title = "Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study",

abstract = "The purpose of this study was to determine the risk of adverse cardiovascular events associated with concomitant use of clopidogrel and calcium-channel blockers (CCBs) in patients with myocardial infarction (MI).",

author = "Olesen, {Jonas Bjerring} and Gislason, {Gunnar H} and Charlot, {Mette G} and Fosb{\o}l, {Emil Loldrup} and Charlotte Andersson and Peter Weeke and Ole Ahlehoff and Selmer, {Christian Laust Weise} and Christian Torp-Pedersen and Hansen, {Peter R}",

year = "2011",

month = jan,

day = "25",

doi = "10.1016/j.jacc.2010.08.640",

language = "English",

volume = "57",

pages = "409--17",

journal = "Journal of the American College of Cardiology",

issn = "1558-3597",

publisher = "Elsevier Inc",

number = "4",

}

TY - JOUR

T1 - Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study

AU - Olesen, Jonas Bjerring

AU - Gislason, Gunnar H

AU - Charlot, Mette G

AU - Fosbøl, Emil Loldrup

AU - Andersson, Charlotte

AU - Weeke, Peter

AU - Ahlehoff, Ole

AU - Selmer, Christian Laust Weise

AU - Torp-Pedersen, Christian

AU - Hansen, Peter R

PY - 2011/1/25

Y1 - 2011/1/25

N2 - The purpose of this study was to determine the risk of adverse cardiovascular events associated with concomitant use of clopidogrel and calcium-channel blockers (CCBs) in patients with myocardial infarction (MI).

AB - The purpose of this study was to determine the risk of adverse cardiovascular events associated with concomitant use of clopidogrel and calcium-channel blockers (CCBs) in patients with myocardial infarction (MI).

U2 - 10.1016/j.jacc.2010.08.640

DO - 10.1016/j.jacc.2010.08.640

M3 - Journal article

C2 - 21251580

SN - 1558-3597

VL - 57

SP - 409

EP - 417

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 4

ER -

Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort study

Abstract

Access to Document

Fingerprint

Cite this